In a recent survey of 7,000 Americans, health experts from Hims revealed the biggest sexual kinks in the US. These include ...

Delay in addressing harassment allegations against Dr. H.C. Lokesh at HIMS leaves staff worried, despite inquiry findings.

Hims & Hers achieved a 44% YoY increase in Q3 2024, surpassing 2 million active users. Find out what positions HIMS as a key ...

The bitter irony is that Republican policies in states with high obesity rates only exacerbate the gaps in health outcomes.

Hims & Hers Health Inc is a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals, enabling them to access high-quality medical care for numerous conditions ...

Nutrafol is a leader in supplement-based hair loss treatments, offering a natural way to support healthy hair growth. Their ...

Shares of Hims & Hers were on fire Monday because the FDA's new leader seems to be a fan of the company's business model.

3. Shares of virtual care company Hims & Hers spiked after the news that a telehealth ally could be running the FDA, Bloomberg reported Nov. 25. 4. Sesame provides compounded versions of the popular ...

Hims & Hers Health Inc. shares surged 24% to close at fresh record after Hunterbrook Media said the company is poised to be a ...

Cassava Sciences ( SAVA) stock dropped 87% on Monday to close the day’s trading at $4.29 a shares. Cassava is a biotechnology ...

Looking for a solution for hair loss can feel like a huge undertaking. With the overwhelming number of brands to choose from ...

After going short the stock in June based on Hunterbrook Media’s reporting, Hunterbrook Capital said today it is long Hims & Hers Health.